YECO
EV Biologics, Inc. [YECO] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
YECO Stock Summary
Top 10 Correlated Stocks
YECO
In the News
YECO Financial details
Company Rating
-
Market Cap
4.35M
Income
-1.04M
Revenue
48.9K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
284
Optionable
No
Shortable
Yes
Earnings
31 Dec 2017
P/E
0
Forward P/E
-
PEG
-
P/S
0.65
P/B
-
P/C
-
P/FCF
-16.22
Quick Ratio
0.56
Current Ratio
3.11
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.13
EPS next Y
-
EPS next Q
-
EPS this Y
-95.88%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-55.83%
-
-
-
-
SMA20
-
SMA50
-18.18%
SMA100
-64%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-2%
ROC
-
Gross Margin
16%
Oper. Margin
1%
Profit Margin
-6%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.563-1.95
52W High
-
52W Low
-
RSI
30.1
Rel Volume
-
Avg Volume
106
Volume
Perf Week
0%
Perf Month
0%
Perf Quarter
-64.17%
Perf Half Y
-64.17%
-
-
-
-
Beta
0.390943
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.086
Change
0%
Company Profile
- Volume Average 106
- Market Capitalization 4.35M
- Employee 284
- CEO Mr. Daniel S. McKinney
- Headquarters Cheyenne,WY,US
- IPO Date 2015-06-29
-
Website
https://www.evbiologics.com 
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
